Results 211 to 220 of about 117,049 (245)

Mucocutaneous disease: a child with extrapulmonary manifestation of mycoplasma infection. [PDF]

Einstein (Sao Paulo)
Silva KRPD, Sardini Covello Giaccio R, Martins de Aquino B, Abellan Van Moorsel M, Mazziero Pires F, Hélène CM, Hélène SMF.   +6 more
europepmc   +1 more source

Effectiveness of Peripheral Nerve Block for Early Active Exercise: Three Cases of Pyogenic Flexor Tenosynovitis. [PDF]

Case Rep Orthop
Sato T, Shirahata T, Nozaka K, Miyakoshi N.   +3 more
europepmc   +1 more source

Cutaneous Lesion Induced by a Subcutaneous Administration of Bortezomib [PDF]

Clinical Lymphoma Myeloma and Leukemia, 2012
Introduction A 78-year-old man presented to our hospital with an indurated, painful lesion on the abdominal wall at the site of a recent subcutaneous (SC) bortezomib injection. The patient was diagnosed with multiple myeloma (MM) in 2007 after a bone marrow biopsy was done as part of anemia workup.
Richard Ferrara, Karam M. Obeid, Mamta Sharma   +2 more
openaire   +2 more sources

Central administration of perfluorooctanoic acid inhibits cutaneous inflammation [PDF]

Inflammation Research, 2005
To elucidate the site of action of perfluorooctanoic acid (PFOA) in the carrageenan model of peripheral inflammation.Male Sprague-Dawley rats.We first compared the anti-edema effects of systemic PFOA (50-150 mg/kg) with prototypical nonsteroidal (acetylsalicylic acid, ASA, 50-200 mg/kg) and steroidal (dexamethasone, 0.5-5.0 mg/kg) drugs after the ...
S. Nagalingam, N. Dadia, C. Kriedt, Bradley K. Taylor, Mostafa Z. Badr   +4 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Cutaneous Administration of Nitroglycerin: A Review

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1983
Chronic administration of nitroglycerin may have important therapeutic effects in patients with angina, acute myocardial infarction, congestive heart failure and peripheral vascular disease. Because of unpredictable oral absorption and short duration of action, topical preparations provide an alternative mode of administration.
Jay N. Cohn, Maria-Teresa Olivari
openaire   +3 more sources

Cutaneous toxicity following the administration of dactinomycin

Medical and Pediatric Oncology, 1997
Dactinomycin (AMD) is an effective drug in the management of several malignant disorders and has been used for almost 40 years. Skin and subcutaneous toxicities following extravasation are well known and can be harmful. Similarly radiation-recall is a well established phenomenon following the administration of AMD.
John P. Arlette, Max J. Coppes, Keith Jorgenson   +2 more
openaire   +2 more sources